Inhalations Sciences: US patent extended until 2034
(Stockholm August 16, 2021) Inhalation Sciences’ US patent protection on its unique aerosol generation system PreciseInhale[® ]has been extended until 2034. Increasing global presence has been a key strategy for ISAB in 2021, with the US as a priority market.ISAB’s first US patent application was submitted on July 16, 2014, when it was approved up until December 1, 2020 under the number 10,850,289. The patent has now been extended and is valid until August 21, 2034. PreciseInhale[®] delivers exceptionally precise preclinical data that significantly reduces risk in inhaled drug